Glamcyst-M Tablet SR
Marketer
Glamcure Lifesciences Private Limited
Salt Composition
Metformin (500mg) + Myo-Inositol (600mg)
Overview Glamcyst-M Tablet SR
Metformin and Myo-inositol Extended-Release tablets manage polycystic ovary syndrome (PCOS) symptoms by regulating ovulation and menstrual cycles. This dual-action formulation improves insulin sensitivity and hormonal equilibrium, contributing to better overall health. Dosage and duration should strictly follow your physician's instructions; take with food, consistently at the same time daily. For missed doses, take immediately unless nearing the next scheduled dose; avoid doubling up. Potential temporary side effects, including altered taste perception, nausea, diarrhea, vomiting, abdominal discomfort, and appetite changes, are possible but usually self-limiting. Persistent or concerning side effects require immediate medical attention. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions, and if pregnant or breastfeeding. Pre-treatment kidney function assessment is standard procedure. Limit alcohol consumption to minimize potential side effect risks.
Primary Ingredients of Glamcyst-M Tablet SR
No text provided to rephrase.
Uses of Glamcyst-M Tablet SR
Managing Polycystic Ovary Syndrome (PCOS)
Major Benefits of Glamcyst-M Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glamcyst-M Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with food.
Common Side effects of Glamcyst-M Tablet SR:
- Taste change
- Dizziness
- Stomach pain
- Nausea
- Diarrhea
- Loss of appetite
How to use Glamcyst-M Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glamcyst-M Tablet SR with a meal.
How Glamcyst-M Tablet SR works:
Extended-release Glamcyst-M tablets contain a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Glamcyst-M Tablet SR and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Data on Glamcyst-M Tablet SR use in pregnancy is lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Glamcyst-M Tablet SR use while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glamcyst-M Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glamcyst-M Tablet SR use. Physician consultation is recommended. Routine monitoring of kidney function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glamcyst-M Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glamcyst-M Tablet SR :
Should you forget to take a Glamcyst-M Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glamcyst-M Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |


